TrailBio® PD0325901

$250.00

Selective MEK inhibitor for MAPK/ERK signaling 

  • Selective, non-ATP-competitive MEK inhibitor used to regulate MAPK/ERK signaling in cell signaling and disease-modeling workflows.
  • Reported to reduce ERK1/2 phosphorylation in cell-based assays.
  • Enhances iPSC generation and fibroblast reprogramming efficiency, including workflows using PD0325901 in combination with SB-431542 and Thiazovivin.
  • Supports stem cell research workflows involving pluripotency maintenance, lineage-directed differentiation, apoptosis, and autophagy.
SKU: N/A Category:

Description

Technical Information & Resources

Supporting Publications

Ying et al. (2008), Nature

  • This foundational paper established that inhibition of ERK signaling with PD0325901, together with GSK3 inhibition, supports mouse embryonic stem cell self-renewal and pluripotency maintenance.

Silva et al. (2008), PLOS Biology

  • Study shows that MEK/ERK pathway inhibition with PD0325901, combined with pluripotency-supporting pathway modulation, promoted reprogramming toward a ground-state pluripotent stem cell identity.

Lin et al. (2009), Nature Methods

Nichols et al. (2009), Development

  • Study describes that suppression of ERK signaling, including use of PD0325901 with CHIR99021 (Cat No. TB54925), supports pluripotent epiblast/ES cell derivation and helps shield pluripotent cells from differentiation-inducing signaling.

Additional information

Also Known As

Mirdametinib; PD325901

Chemical Name

N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

CAS Number

391210-10-9

Purity

≥98%

Formula

C16H14F3IN2O4

Molecular Weight

482.19 g/mol

Usage

For research use only

Storage (Solid)

4 °C for up to 2 years, protect from light

Storage (Solution)

-80 °C for up to 6 months or -20 °C for up to 1 month, protect from light

Form

Powder

Shipping

Ambient temperature